--:--:--
Stockwatch Reports
…

News Reports / Healthcare / FTRE

FTREFortrea Holdings Inc.

NasdaqGS · Healthcare · Mkt cap $2.2B · Avg vol 1.59M

$23.14

-2.74 (-10.58%)

Quote as of October 29, 2026, 2:07 PM ET

News Impact Report · Published October 29, 2026, 9:53 AM ET

FTRE: Fortrea Holdings Posts $562.9M Net Loss and $850.4M Operating Loss in Q2 FY2026

Share

Fortrea Holdings Inc. (NASDAQ: FTRE) | Price: $23.18 | Today's Change: -10.45%


What Happened

Fortrea Holdings filed an 8-K (Items 2.02 and 9.01) with the SEC on October 29, 2026, disclosing its Q2 FY2026 financial results. The company reported revenue of $1.361 billion for the quarter, alongside a net loss of $562.9 million and a staggering operating loss of $850.4 million. Earnings per share on both a basic and diluted basis came in at -$10.37, underscoring the depth of the loss relative to the company's share count.


Why It Matters

The scale of the operating loss — $850.4 million against $1.36 billion in revenue — implies that operating costs and/or impairment charges dramatically exceeded the company's top-line generation during the quarter. Key points for investors to note:

  • Revenue of $1.36 billion shows the business continues to generate meaningful top-line activity, but profitability is severely impaired.
  • An operating loss of -$850.4 million represents a loss-to-revenue ratio of roughly 62%, a level that signals either significant non-cash charges (such as goodwill impairments), restructuring costs, or fundamental margin deterioration — the filing metadata alone does not decompose the exact drivers, and investors should review the full financial statements attached under Item 9.01 for that detail.
  • A net loss of -$562.9 million (somewhat narrower than the operating loss) suggests some offsetting items below the operating line, though the company still posts a deeply negative bottom line.
  • The stock's -10.45% intraday decline directly reflects market reaction to these figures.

Analysis

The Q2 FY2026 results represent a significant negative data point for Fortrea. The gap between the operating loss (-$850.4M) and the net loss (-$562.9M) is notable — roughly $287 million of items below the operating line moved in the company's favor, which could reflect tax benefits, gains on financial instruments, or other items. However, this does not change the fundamental picture: Fortrea is burning through value at an alarming rate relative to its revenue base.

The revenue figure of $1.36 billion indicates the contract research organization (CRO) business is still operational at scale, which matters — the question is whether the losses reflect transitory charges (write-downs, restructuring) or a structural deterioration in the underlying business model. That distinction is critical for how the stock is valued going forward.

StockWatch initiated coverage on FTRE on October 6, 2026 — just weeks before this filing — and this disclosure represents the first major earnings event since that initiation. Investors should read today's figures in the context of that existing research.

What to watch next:

  • Management's explanation of the specific drivers behind the $850.4M operating loss — particularly any goodwill impairments or restructuring charges
  • Updated full-year guidance, if provided
  • Any commentary on the pace of revenue backlog conversion and client retention

Disclaimer

This report is a news and informational summary based solely on data contained in Fortrea Holdings' SEC filing and is intended for general informational purposes only. It does not constitute investment advice, an offer to buy or sell securities, or an equity research recommendation of any kind. Readers should conduct their own due diligence and consult a qualified financial adviser before making any investment decisions.

Existing Coverage

StockWatch has full coverage on FTRE, published 2026-10-06. Read our Initiating Coverage →

Source

Filed with the SEC on 2026-10-29. Read the original filing on EDGAR: https://www.sec.gov/Archives/edgar/data/1965040/000196504026000146/ftre-20261029.htm

StockWatch initiated coverage · October 6, 2026

FTRE: Contract Research Rebound Hinges on Post-Spin Stabilization

A stock at the top of its range with a damaged earnings base. FTRE trades at $22.54, literally at its 52-week high of $23.51 and roughly 164% above its 52-week low of $8.55, yet reported EPS is -$0.91. The market is paying for a recovery that has not yet appeared in GAAP earnings, which makes execution risk asymmetric at this price. Short interest is the loudest signal in the data set. With 12.55M shares short (Sep 15, 2026) against a 93.98M public float, 15.50% of the float is shor

+2.7%

Read the full report →

+2.7%

Key Data

Last

$23.18

P&L ($)

$-2.70

P&L (%)

-10.45%

Day Range

$22.41 - $23.79

Volume

194.66K

Market Cap

$2.2B

Previous Close

$25.88

Open

$23.63

52 Week Range

$8.55 - $26.16

Shares Outstanding

95.10M

Public Float

93.98M

Average Volume

1.59M

As of October 29, 2026, 10:41 AM ET

Advertise here
Stockwatch Reports

Free stock market updates, top gainers & losers, and AI-generated stock analyses — updated daily. Real-time price movements, quotes, and coverage for German & U.S. stoc